(FDS) FactSet Research Systems - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3030751057
Stock: Workstation, Analytics, Data, Feeds, Platform
Total Rating 43
Risk 81
Buy Signal -1.27
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.16% |
| Yield on Cost 5y | 1.42% |
| Yield CAGR 5y | 7.66% |
| Payout Consistency | 99.6% |
| Payout Ratio | 25.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 49.3% |
| Relative Tail Risk | -2.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.42 |
| Alpha | -66.42 |
| Character TTM | |
|---|---|
| Beta | 0.611 |
| Beta Downside | 0.533 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.60% |
| CAGR/Max DD | -0.36 |
Description: FDS FactSet Research Systems January 02, 2026
FactSet Research Systems Inc. (NYSE:FDS) delivers a cloud-enabled financial data and analytics platform to the global investment community, offering subscription-based market intelligence, portfolio-analytics workstations, and managed services that span the entire investment lifecycle-from idea generation to risk reporting.
Key operating metrics (FY 2023) include ≈ $2.0 billion in revenue, a 10% YoY growth in subscription ARR, and a client base of over 13,000 institutional users, reflecting the sector’s shift toward SaaS-based, low-code analytics solutions. The firm’s performance is sensitive to macro drivers such as rising demand for ESG and alternative-data feeds, as well as heightened regulatory reporting requirements that push asset managers toward integrated data-management tools.
FactSet’s diversified geographic footprint-covering North America, EMEA, and APAC-helps mitigate regional economic cycles, while its API-first strategy supports fintech partnerships and expands data-distribution channels.
For a deeper quantitative view of FactSet’s valuation dynamics, you might explore the ValueRay platform’s analyst models.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 599.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 2.09 > 1.0 |
| NWC/Revenue: 10.58% < 20% (prev 9.53%; Δ 1.05% < -1%) |
| CFO/TA 0.18 > 3% & CFO 761.2m > Net Income 599.6m |
| Net Debt (1.28b) to EBITDA (984.1m): 1.31 < 3 |
| Current Ratio: 1.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.6m) vs 12m ago -2.34% < -2% |
| Gross Margin: 52.26% > 18% (prev 0.54%; Δ 5172 % > 0.5%) |
| Asset Turnover: 57.10% > 50% (prev 55.07%; Δ 2.03% > 0%) |
| Interest Coverage Ratio: 14.22 > 6 (EBITDA TTM 984.1m / Interest Expense TTM 55.3m) |
Altman Z'' 4.76
| A: 0.06 (Total Current Assets 708.6m - Total Current Liabilities 458.8m) / Total Assets 4.22b |
| B: 0.58 (Retained Earnings 2.44b / Total Assets 4.22b) |
| C: 0.19 (EBIT TTM 786.5m / Avg Total Assets 4.13b) |
| D: 1.15 (Book Value of Equity 2.36b / Total Liabilities 2.05b) |
| Altman-Z'' Score: 4.76 = AA |
Beneish M -2.91
| DSRI: 1.08 (Receivables 289.0m/252.5m, Revenue 2.36b/2.23b) |
| GMI: 1.04 (GM 52.26% / 54.29%) |
| AQI: 1.02 (AQ_t 0.78 / AQ_t-1 0.77) |
| SGI: 1.06 (Revenue 2.36b / 2.23b) |
| TATA: -0.04 (NI 599.6m - CFO 761.2m) / TA 4.22b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of FDS shares?
As of February 07, 2026, the stock is trading at USD 207.32 with a total of 1,264,813 shares traded.
Over the past week, the price has changed by -18.49%, over one month by -29.19%, over three months by -17.93% and over the past year by -55.31%.
Over the past week, the price has changed by -18.49%, over one month by -29.19%, over three months by -17.93% and over the past year by -55.31%.
Is FDS a buy, sell or hold?
FactSet Research Systems has received a consensus analysts rating of 2.67.
Therefor, it is recommend to hold FDS.
- StrongBuy: 2
- Buy: 0
- Hold: 12
- Sell: 3
- StrongSell: 4
What are the forecasts/targets for the FDS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 322.1 | 55.4% |
| Analysts Target Price | 322.1 | 55.4% |
| ValueRay Target Price | 183.6 | -11.4% |
FDS Fundamental Data Overview February 03, 2026
P/E Trailing = 16.0784
P/E Forward = 14.5138
P/S = 4.0319
P/B = 4.326
P/EG = 1.4659
Revenue TTM = 2.36b USD
EBIT TTM = 786.5m USD
EBITDA TTM = 984.1m USD
Long Term Debt = 1.37b USD (from longTermDebt, last quarter)
Short Term Debt = 32.6m USD (from shortTermDebt, last quarter)
Debt = 1.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.28b USD (from netDebt column, last quarter)
Enterprise Value = 10.80b USD (9.52b + Debt 1.56b - CCE 275.4m)
Interest Coverage Ratio = 14.22 (Ebit TTM 786.5m / Interest Expense TTM 55.3m)
EV/FCF = 16.69x (Enterprise Value 10.80b / FCF TTM 647.4m)
FCF Yield = 5.99% (FCF TTM 647.4m / Enterprise Value 10.80b)
FCF Margin = 27.42% (FCF TTM 647.4m / Revenue TTM 2.36b)
Net Margin = 25.40% (Net Income TTM 599.6m / Revenue TTM 2.36b)
Gross Margin = 52.26% ((Revenue TTM 2.36b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 52.62% (prev 51.64%)
Tobins Q-Ratio = 2.56 (Enterprise Value 10.80b / Total Assets 4.22b)
Interest Expense / Debt = 0.86% (Interest Expense 13.4m / Debt 1.56b)
Taxrate = 19.74% (37.5m / 190.1m)
NOPAT = 631.3m (EBIT 786.5m * (1 - 19.74%))
Current Ratio = 1.54 (Total Current Assets 708.6m / Total Current Liabilities 458.8m)
Debt / Equity = 0.72 (Debt 1.56b / totalStockholderEquity, last quarter 2.17b)
Debt / EBITDA = 1.31 (Net Debt 1.28b / EBITDA 984.1m)
Debt / FCF = 1.98 (Net Debt 1.28b / FCF TTM 647.4m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.50% (Net Income 599.6m / Total Assets 4.22b)
RoE = 28.00% (Net Income TTM 599.6m / Total Stockholder Equity 2.14b)
RoCE = 22.41% (EBIT 786.5m / Capital Employed (Equity 2.14b + L.T.Debt 1.37b))
RoIC = 17.77% (NOPAT 631.3m / Invested Capital 3.55b)
WACC = 7.12% (E(9.52b)/V(11.08b) * Re(8.17%) + D(1.56b)/V(11.08b) * Rd(0.86%) * (1-Tc(0.20)))
Discount Rate = 8.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.34%
[DCF Debug] Terminal Value 82.45% ; FCFF base≈603.0m ; Y1≈654.1m ; Y5≈815.0m
Fair Price DCF = 426.5 (EV 17.11b - Net Debt 1.28b = Equity 15.82b / Shares 37.1m; r=7.12% [WACC]; 5y FCF grow 9.62% → 2.90% )
EPS Correlation: 58.70 | EPS CAGR: 5.94% | SUE: 1.12 | # QB: 1
Revenue Correlation: 94.33 | Revenue CAGR: 9.58% | SUE: 1.54 | # QB: 3
EPS next Quarter (2026-05-31): EPS=4.42 | Chg30d=+0.001 | Revisions Net=+2 | Analysts=14
EPS current Year (2026-08-31): EPS=17.49 | Chg30d=+0.011 | Revisions Net=+13 | Growth EPS=+3.0% | Growth Revenue=+5.5%
EPS next Year (2027-08-31): EPS=19.01 | Chg30d=+0.212 | Revisions Net=+12 | Growth EPS=+8.6% | Growth Revenue=+5.3%
P/E Forward = 14.5138
P/S = 4.0319
P/B = 4.326
P/EG = 1.4659
Revenue TTM = 2.36b USD
EBIT TTM = 786.5m USD
EBITDA TTM = 984.1m USD
Long Term Debt = 1.37b USD (from longTermDebt, last quarter)
Short Term Debt = 32.6m USD (from shortTermDebt, last quarter)
Debt = 1.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.28b USD (from netDebt column, last quarter)
Enterprise Value = 10.80b USD (9.52b + Debt 1.56b - CCE 275.4m)
Interest Coverage Ratio = 14.22 (Ebit TTM 786.5m / Interest Expense TTM 55.3m)
EV/FCF = 16.69x (Enterprise Value 10.80b / FCF TTM 647.4m)
FCF Yield = 5.99% (FCF TTM 647.4m / Enterprise Value 10.80b)
FCF Margin = 27.42% (FCF TTM 647.4m / Revenue TTM 2.36b)
Net Margin = 25.40% (Net Income TTM 599.6m / Revenue TTM 2.36b)
Gross Margin = 52.26% ((Revenue TTM 2.36b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 52.62% (prev 51.64%)
Tobins Q-Ratio = 2.56 (Enterprise Value 10.80b / Total Assets 4.22b)
Interest Expense / Debt = 0.86% (Interest Expense 13.4m / Debt 1.56b)
Taxrate = 19.74% (37.5m / 190.1m)
NOPAT = 631.3m (EBIT 786.5m * (1 - 19.74%))
Current Ratio = 1.54 (Total Current Assets 708.6m / Total Current Liabilities 458.8m)
Debt / Equity = 0.72 (Debt 1.56b / totalStockholderEquity, last quarter 2.17b)
Debt / EBITDA = 1.31 (Net Debt 1.28b / EBITDA 984.1m)
Debt / FCF = 1.98 (Net Debt 1.28b / FCF TTM 647.4m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.50% (Net Income 599.6m / Total Assets 4.22b)
RoE = 28.00% (Net Income TTM 599.6m / Total Stockholder Equity 2.14b)
RoCE = 22.41% (EBIT 786.5m / Capital Employed (Equity 2.14b + L.T.Debt 1.37b))
RoIC = 17.77% (NOPAT 631.3m / Invested Capital 3.55b)
WACC = 7.12% (E(9.52b)/V(11.08b) * Re(8.17%) + D(1.56b)/V(11.08b) * Rd(0.86%) * (1-Tc(0.20)))
Discount Rate = 8.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.34%
[DCF Debug] Terminal Value 82.45% ; FCFF base≈603.0m ; Y1≈654.1m ; Y5≈815.0m
Fair Price DCF = 426.5 (EV 17.11b - Net Debt 1.28b = Equity 15.82b / Shares 37.1m; r=7.12% [WACC]; 5y FCF grow 9.62% → 2.90% )
EPS Correlation: 58.70 | EPS CAGR: 5.94% | SUE: 1.12 | # QB: 1
Revenue Correlation: 94.33 | Revenue CAGR: 9.58% | SUE: 1.54 | # QB: 3
EPS next Quarter (2026-05-31): EPS=4.42 | Chg30d=+0.001 | Revisions Net=+2 | Analysts=14
EPS current Year (2026-08-31): EPS=17.49 | Chg30d=+0.011 | Revisions Net=+13 | Growth EPS=+3.0% | Growth Revenue=+5.5%
EPS next Year (2027-08-31): EPS=19.01 | Chg30d=+0.212 | Revisions Net=+12 | Growth EPS=+8.6% | Growth Revenue=+5.3%